Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.395 USD | -15.67% | -37.98% | -65.09% |
05-20 | SAB Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-06 | SAB Biotherapeutics, Inc. Appoints Jay Skyler, Md, to the Board of Directors | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-65.09% | 26.2M | |
+11.16% | 115B | |
+12.82% | 106B | |
-4.59% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-11.59% | 17.56B | |
-40.50% | 17.32B | |
+7.43% | 14.03B | |
+32.98% | 12.13B |
- Stock Market
- Equities
- SABS Stock
- News SAB Biotherapeutics, Inc.
- HC Wainwright Starts SAB Biotherapeutics at Buy With $4 Price Target